Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 38 of 38 entries
Sorted by: Best Match Show Resources per page
Editorial: "Natural Products as a Tool to Design New anti-MDR Lead Molecules.".

Frontiers in pharmacology

Rijo P, Estévez F, Sitarek P, Ferreira MU.
PMID: 34234680
Front Pharmacol. 2021 Jun 21;12:694674. doi: 10.3389/fphar.2021.694674. eCollection 2021.

No abstract available.

Cite
Rijo P, Estévez F, Sitarek P, et al. Editorial: "Natural Products as a Tool to Design New anti-MDR Lead Molecules.". Front Pharmacol. 2021;12:694674doi: 10.3389/fphar.2021.694674.
Rijo, P., Estévez, F., Sitarek, P., & Ferreira, M. U. (2021). Editorial: "Natural Products as a Tool to Design New anti-MDR Lead Molecules.". Frontiers in pharmacology, 12694674. https://doi.org/10.3389/fphar.2021.694674
Rijo, Patrícia, et al. "Editorial: "Natural Products as a Tool to Design New anti-MDR Lead Molecules."." Frontiers in pharmacology vol. 12 (2021): 694674. doi: https://doi.org/10.3389/fphar.2021.694674
Rijo P, Estévez F, Sitarek P, Ferreira MU. Editorial: "Natural Products as a Tool to Design New anti-MDR Lead Molecules.". Front Pharmacol. 2021 Jun 21;12:694674. doi: 10.3389/fphar.2021.694674. eCollection 2021. PMID: 34234680; PMCID: PMC8255960.
Copy Download .nbib Format: NLM
Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis.

British journal of pharmacology

Mergault C, Lisée F, Tiroille V, Magnien M, Parent C, Lenga Mabonda W, Sizaret D, Jaillet M, Crestani B, Marchand-Adam S, Plantier L.
PMID: 34453744
Br J Pharmacol. 2021 Aug 28; doi: 10.1111/bph.15675. Epub 2021 Aug 28.

BACKGROUND AND PURPOSE: The Arp2/3 multiprotein complex regulates branched polymerisation of the actin cytoskeleton and may contribute to collagen synthesis and fibrogenesis in the lung.EXPERIMENTAL APPROACH: Expression of Arp2/3 components was assessed in human lung fibroblasts and in the...

Cite
Mergault C, Lisée F, Tiroille V, et al. Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis. Br J Pharmacol. 2021;doi: 10.1111/bph.15675.
Mergault, C., Lisée, F., Tiroille, V., Magnien, M., Parent, C., Lenga Mabonda, W., Sizaret, D., Jaillet, M., Crestani, B., Marchand-Adam, S., & Plantier, L. (2021). Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis. British journal of pharmacology, . https://doi.org/10.1111/bph.15675
Mergault, Coralie, et al. "Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis." British journal of pharmacology vol. (2021). doi: https://doi.org/10.1111/bph.15675
Mergault C, Lisée F, Tiroille V, Magnien M, Parent C, Lenga Mabonda W, Sizaret D, Jaillet M, Crestani B, Marchand-Adam S, Plantier L. Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin-induced pulmonary fibrosis. Br J Pharmacol. 2021 Aug 28; doi: 10.1111/bph.15675. Epub 2021 Aug 28. PMID: 34453744.
Copy Download .nbib Format: NLM
Showing 37 to 38 of 38 entries